Cindy M. Pabon/X
Jan 25, 2025, 12:41
Cindy M. Pabon: Neoadjuvant chemoRT with or without sintilimab for ESCC
Cindy M. Pabon, Assistant Professor of Gastrointestinal Medical Oncology at The University of Miami Sylvester Comprehensive Cancer Center, posted on X:
“Xuefeng Leng presents neoadjuvant chemoRT with/without sintilimab for ESCC. Statistically significant improvement in pCR rates…but is this similar to the reduction in disease we see with CHECKMATE-577? Will need long term survival data for both studies to see if sequence matters.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41
Jan 25, 2025, 12:41